
Veeva Submissions Archive
A global, secure repository for managing and accessing submission published outputs to health authorities.
Overview
Veeva Submissions Archive is a comprehensive global repository designed for securing submission published outputs. It serves as the authoritative source for the applications submitted to health authorities worldwide.
The repository is equipped with a dynamic search, filtering, and navigation system, which allows users to easily manage extensive records. It supports a viewer capable of handling all electronic and paper formats, with PDF link navigation specifically for electronic formats, facilitating streamlined access to submissions and correspondence with health authorities alongside previously submitted applications.
The Active Dossier feature provides a snapshot of currently active submission components for any specific product or market. This contributes to maintaining regulatory compliance and efficiency.
- Control user access: Share content selectively by applying configured business rules, ensuring the right people have appropriate access.
- Track health authority correspondence and commitments: Easily locate and manage regulatory dossiers, including those dispatched by regional or local affiliates.
- Maintain global readiness: Enable remote team members to access authorized submissions from any global location, enhancing collaboration and productivity.
Many top companies, including 15 of the top 20, use Veeva RIM due to proven impacts such as the consolidation of 88 IT systems into one and a significant 90% reduction in written standards. The system is trusted by over 400 leading and emerging biopharmaceutical businesses.
Real-world testimonials highlight the platform's effectiveness. Users like Rich Fredericks from Mersana note its role as a single source for cross-organizational quality control and reviews. Juhi Saxena from Moderna appreciates the efficiency boost in regional impact assessments, while a vice president from bluebird bio acknowledges the strategy's long-term value to their investment in regulatory operations.
